Translator Disclaimer
1 December 2010 Characterization of Recombinant Raccoonpox Vaccine Vectors in Chickens
Author Affiliations +
Abstract

Raccoonpox virus (RCN) has been used as a recombinant vector against several mammalian pathogens but has not been tested in birds. The replication of RCN in chick embryo fibroblasts (CEFs) and chickens was studied with the use of highly pathogenic avian influenza virus H5N1 hemagglutinin (HA) as a model antigen and luciferase (luc) as a reporter gene. Although RCN replicated to low levels in CEFs, it efficiently expressed recombinant proteins and, in vivo, elicited anti-HA immunoglobulin yolk (IgY) antibody responses comparable to inactivated influenza virus. Biophotonic in vivo imaging of 1-wk-old chicks with RCN-luc showed strong expression of the luc reporter gene lasting up to 3 days postinfection. These studies demonstrate the potential of RCN as a vaccine vector for avian influenza and other poultry pathogens.

Shi-Hsia Hwa, Keith P. Iams, Jeffrey S. Hall, Brock A. Kingstad, and Jorge E. Osorio "Characterization of Recombinant Raccoonpox Vaccine Vectors in Chickens," Avian Diseases 54(4), 1157-1165, (1 December 2010). https://doi.org/10.1637/9315-032410-Reg.1
Received: 27 March 2010; Accepted: 1 June 2010; Published: 1 December 2010
JOURNAL ARTICLE
9 PAGES


SHARE
ARTICLE IMPACT
RIGHTS & PERMISSIONS
Get copyright permission
Back to Top